Prognostic value of circulating glypican-4 in patients with chronic heart failure with reduced ejection fraction

30 August 2024 (08:00 - 17:30)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Nora Schwegel

Medical University of Graz, Graz (Austria)

8 More presentations in this session

Presentation thumbnail

Association of Vascular endothelial factor D with pulmonary hypertension in heart failure: the PREHOSP-CHF Study

Doctor M. Iguchi (Kyoto, JP)

Abstract Slides

Presentation thumbnail

Association between GDF-15 levels and cardiac morphology and function in cardiac magnetic resonance imaging: insights from UK Biobank data analysis

Doctor P. Nowek (Olsztyn, PL)

Abstract Slides

Presentation thumbnail

Circulating secretoneurin concentrations predict 90-day mortality in patients with cardiogenic shock

Professor H. Rosjo (Nordbyhagen, NO)

Abstract Slides

Presentation thumbnail

Interleukin-6 and suPAR are associated with diastolic function in type 1 diabetes: The Thousand & 1 Study

Doctor H. Bahrami (Herlev, DK)

Abstract Slides

Presentation thumbnail

Association of osteopontin and shrunken pore syndrome with hospitalization for renal failure in acute heart failure patients

Doctor M. Ohlsson (Malmo, SE)

Abstract Slides Video

Access the full session

Session thumbnail

Studies of new biomarkers in heart failure

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024

You may be interested in

Congress Presentation

The role of a multimarker panel in the diagnosis and prognosis of patients with acute heart failure

Congress Presentation

Novel biomarkers reveal distinct biological phenotypes in heart failure with preserved vs reduced ejection fraction

Congress Session

From genetic signatures to clinical implications

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources